hyperparathyroidism

hyperparathyroidism is a topic covered in the Taber's Medical Dictionary.

To view the entire topic, please or purchase a subscription.

Nursing Central is the award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:

Nursing Central

-- The first section of this topic is shown below --

(hī″pĕr-par″ă-thī′royd-ĭzm )

[hyper- + parathyroid + -ism]
A condition caused by excessive levels of parathyroid hormone in the body.
SEE: hypercalcemia; SEE: parathyroid glands; SEE: osteitis fibrosa cystica

INCIDENCE
Primary hyperparathyroidism is found in about 21 people per 100,000. Most patients with hyperparathyroidism are older women.

CAUSES
Hyperparathyroidism is usually caused by an adenoma (benign tumor) of the parathyroid glands (primary hyperparathyroidism). Occasionally it occurs secondary to renal failure or other systemic illnesses. About 90% of the time, a single parathyroid adenoma is the cause. In about 10% of patients, generalized hyperplasia is found in all four parathyroid glands.

SYMPTOMS AND SIGNS
Hyperparathyroidism is the most common cause of hypercalcemia, which can lead to central nervous system, musculoskeletal, metabolic, gastrointestinal, and cardiovascular problems when the concentration of calcium in the blood rises to very high levels (>11 mg/dL). Common consequences of excess parathyroid hormone include symptomatic or unnoticed hypercalcemia, hypophosphatemia, hyperchlorhydria, kidney stone formation, and bone resorption.

PATIENT CARE
Mild hyperparathyroidism may initially be managed expectantly without harm to the patient. Severe primary hyperparathyroidism may require surgical removal of the parathyroid gland or glands to prevent potential complications of hyperparathyroidism, including kidney stone disease, degeneration of bone, neuromuscular and neuropsychiatric illnesses, and pancreatitis. In some cancer patients, malignant tumors release a parathyroid-like hormone with hypercalcemia, which mimics hyperparathyroidism.

-- To view the remaining sections of this topic, please or purchase a subscription --